FDA Inspection
AbbVie Bioresearch CenterAbbVie Bioresearch Center – FDA Inspection, Jan 30, 2024
Record Details
This FDA Inspection record concerns AbbVie Bioresearch Center, with an inspection on January 30, 2024, issued by the New England District Office, covering human drugs.
- Company
- AbbVie Bioresearch Center
- Inspection Date
- January 30, 2024
- Product Type
- Human Drugs
View Company Profile
ID · ce4a7b12-128c-4d9d-ae43-62d59d3877a3
Inspection Facts
- Inspection number
- 1252835
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of AbbVie Bioresearch Center
12| Date | Classification | Office | Project area |
|---|---|---|---|
| December 16, 2025 | Not classified | New England District Office | |
| September 5, 2025 | Not classified | New England District Office | |
| November 18, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 24, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 11, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AbbVie Bioresearch Center
- FDA Inspection 1295502 - 2025-12-16
- FDA Inspection 1272372 - 2025-09-05
- FDA Inspection 1113080 - 2019-11-18
- FDA Inspection 1056813 - 2018-05-24
- FDA Inspection 1010336 - 2017-04-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.